Results 51 to 60 of about 124,009 (365)

An Unusual Salivary Gland Tumor Mimicking Papillary Thyroid Carcinoma: Mammary Analog Secretory Carcinoma

open access: yesFrontiers in Endocrinology, 2018
Thyroid tumors usually present as masses in the thyroid gland. While the majority of these tumors represent neoplasms of thyroid tissues, mainly of follicular epithelial cell differentiation, the differential diagnosis includes other lesions, such as C ...
Sylvia L. Asa   +3 more
doaj   +1 more source

Current concepts in diagnosis of unusual salivary gland tumors

open access: yesDental Research Journal, 2012
Salivary gland tumors are relatively uncommon and account for approximately 3-6% of all neoplasms of the head and neck. Tumors mostly involve the major salivary glands, 42.9-90% of which occur in the parotid glands and 8-19.5% in the sub-mandibular ...
Ajay Kumar Bansal   +4 more
doaj   +1 more source

Analysis of the clinical relevance of histological classification of benign epithelial salivary gland tumours [PDF]

open access: yes, 2019
IntroductionA vast increase in knowledge of numerous aspects of malignant salivary gland tumours has emerged during the last decade and, forseveral reasons, thishas not been the case in benign epithelial salivary gland tumours.
Andreasen, Simon   +10 more
core   +4 more sources

Cytology of Primary Salivary Gland-Type Tumors of the Lower Respiratory Tract: Report of 15 Cases and Review of the Literature. [PDF]

open access: yes, 2017
Primary pulmonary salivary gland-type tumors are rare neoplasms arising from the seromucinous submucosal glands of the lower respiratory tract (LRT), the most common of which are mucoepidermoid carcinoma (MEC) and adenoid cystic carcinoma.
Bongiovanni, M.   +6 more
core   +4 more sources

Mucoepidermoid Carcinoma of Floor of the Mouth – A Rarity [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2015
Mucoepidermoid Carcinoma (MEC) is one of the most commonly occurring malignant salivary gland neoplasm, and contributes 2.8%– 15% of all salivary gland tumours.
Aruna Kumari Maloth   +4 more
doaj   +1 more source

Proliferation PET/CT Imaging of Salivary Gland Tumor

open access: yesDiagnostics, 2021
Salivary gland tumors are rare neoplasms which vary in terms of origin and malignant potential. 2-[18F]-fluoro-2-deoxy-d-glucose (FDG)-positron emission tomography (PET) has limited ability to differentiate between different types of salivary gland ...
Ryogo Minamimoto
doaj   +1 more source

Salivary gland Cytology, the new and the Old, a Pattern-Based approach

open access: yesHuman Pathology Reports
Salivary gland neoplasms are rare and represent a diverse group of tumors. Fine-needle aspiration is a cost effective approach that has been widely applied in preoperative diagnosis of salivary gland lesions to guide clinical management.
Shuo Niu, Yanjun Hou
doaj   +1 more source

Eternal dilemma of the interplay between coexisting tuberculosis and malignancy: Clinical scenario of coexisting submandibular carcinoma with disseminated tuberculosis: A case report

open access: yesAsian Journal of Medical Sciences, 2016
Tuberculosis (TB) and malignancy are two lethal diseases that cause significant morbidity and mortality in developing countries like India. Extrapulmonary tuberculosis (TB) constitutes about 15 to 20 per cent of all cases of tuberculosis with lymph nodes
Manjari Shah
doaj   +1 more source

Recent developments in the pathology of primary pulmonary salivary gland‐type tumours

open access: yesHistopathology, 2023
Primary pulmonary salivary gland‐type tumours are rare neoplasms that are thought to arise from seromucinous glands that are located in the submucosa of large airways.
Julia R. Naso, A. Roden
semanticscholar   +1 more source

Molecular imaging predicts trastuzumab‐deruxtecan (T‐DXd) response in head and neck cancer xenograft models

open access: yesMolecular Oncology, EarlyView.
Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy